Erythropoietin Payments To Major Dialysis Facilities Cut In House Medicare/Child Health Package

"Large" dialysis centers providing erythropoietin-stimulating agents could see Medicare payments reduced to average sales price plus 2 percent, under a Medicare/child health bill scheduled for markup by two House committees July 26. Medicare Part B currently reimburses ESAs at ASP + 6 percent